The company said that the jump in profit after tax (PAT) was because of strong base business growth and one-time help.
Revenue from operations rose 9.8% to Rs 852.53 crore in the quarter ended June 2023 as compared with a year ago, driven by strong brand fundamentals and integrated growth strategy.
Total expenses decreased by 9.42% YoY to Rs 656.05 crore in Q4 June 2023, due to decline in cost of raw and packing materials consumed (down 5.13% YoY) and lower other expenses (down 7.76% YoY).
Profit before tax in the quarter ended June 2023 stood at Rs 206.58 crore as against Rs 57.70 crore recorded in the same period last year.
The company's standalone net profit increased 17.78% to Rs 678.14 crore in the year ended 30 June 2023 from Rs 575.75 crore posted in the corresponding quarter last year. Excluding the one-time tax impacts, PAT was up 10% operationally. This was driven by premiumization and productivity interventions, as the company said it continued to make sequential progress in profit growth, despite the challenging operating and cost environment.
For the fiscal ended 30 June 2023, the company reported sales of Rs 3917.90 crore, flat versus year ago owing to a one-time other operating income and a pandemic-linked demand surge in the healthcare portfolio in the base period.
LV Vaidyanathan, managing director, Procter & Gamble Hygiene and Health Care, said, “We delivered a strong top and bottom-line growth in the quarter, leading up to a resilient finish for the fiscal year despite a challenging operating environment.
We remain committed to our strategy - a focus on daily use categories where performance drives brand choice, superiority (of product, package, communication, go-to-market execution, and value), productivity, constructive disruption, and an agile and accountable organization structure and culture - all in pursuit of sustainable, balanced growth and value creation.”
Meanwhile, the board recommended a final dividend of Rs 105 per equity share for the financial year ended 30 June 2023, subject to the approval of shareholders of the company.
Further, the personal care company informed that Sharath Verma, shall cease to be its chief marketing officer effective 31 August 2023, due a change in his assignment at P&G. Mukta Maheshwari will be appointed as company's chief marketing officer with effect from 1 September 2023. She is an aerospace engineer from IIT and has completed her MBA from IIM, Calcutta. She has an experience of over 23 years, of which she has spent the last 16 years with Procter & Gamble working across multiple geographies.
Procter & Gamble Hygiene and Health Care is one of India's leading FMCG companies that has in its portfolio WHISPER – India's leading feminine hygiene brand, and VICKS – India's No. 1 health care brand and Old Spice.
The counter hit a life-time high of Rs 16,599 on the BSE.
|